275 related articles for article (PubMed ID: 19075016)
1. Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?
Jung-Hynes B; Nihal M; Zhong W; Ahmad N
J Biol Chem; 2009 Feb; 284(6):3823-32. PubMed ID: 19075016
[TBL] [Abstract][Full Text] [Related]
2. Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells.
Jung-Hynes B; Ahmad N
Cell Cycle; 2009 May; 8(10):1478-83. PubMed ID: 19377286
[TBL] [Abstract][Full Text] [Related]
3. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells.
Kojima K; Ohhashi R; Fujita Y; Hamada N; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Aug; 373(3):423-8. PubMed ID: 18573234
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors.
Mai A; Massa S; Lavu S; Pezzi R; Simeoni S; Ragno R; Mariotti FR; Chiani F; Camilloni G; Sinclair DA
J Med Chem; 2005 Dec; 48(24):7789-95. PubMed ID: 16302818
[TBL] [Abstract][Full Text] [Related]
5. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
Li Q; He M; Zhou F; Ye F; Gao SJ
J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
[TBL] [Abstract][Full Text] [Related]
6. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.
Yang Y; Hou H; Haller EM; Nicosia SV; Bai W
EMBO J; 2005 Mar; 24(5):1021-32. PubMed ID: 15692560
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 regulates tyrosine hydroxylase expression and differentiation of neuroblastoma cells via FOXO3a.
Kim MJ; Ahn K; Park SH; Kang HJ; Jang BG; Oh SJ; Oh SM; Jeong YJ; Heo JI; Suh JG; Lim SS; Ko YJ; Huh SO; Kim SC; Park JB; Kim J; Kim JI; Jo SA; Lee JY
FEBS Lett; 2009 Apr; 583(7):1183-8. PubMed ID: 19285077
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of the sirtuin inhibitor sirtinol involves concentration-dependent modulation of multiple nuclear receptor-mediated pathways in androgen-responsive prostate cancer cell LNCaP.
Wang TT; Schoene NW; Kim EK; Kim YS
Mol Carcinog; 2013 Sep; 52(9):676-85. PubMed ID: 22495798
[TBL] [Abstract][Full Text] [Related]
9. SIRT1 negatively regulates HDAC1-dependent transcriptional repression by the RBP1 family of proteins.
Binda O; Nassif C; Branton PE
Oncogene; 2008 May; 27(24):3384-92. PubMed ID: 18193082
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth.
Ma L; Maruwge W; Strambi A; D'Arcy P; Pellegrini P; Kis L; de Milito A; Lain S; Brodin B
Cell Death Dis; 2014 Oct; 5(10):e1483. PubMed ID: 25341037
[TBL] [Abstract][Full Text] [Related]
11. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.
Ota H; Tokunaga E; Chang K; Hikasa M; Iijima K; Eto M; Kozaki K; Akishita M; Ouchi Y; Kaneki M
Oncogene; 2006 Jan; 25(2):176-85. PubMed ID: 16170353
[TBL] [Abstract][Full Text] [Related]
12. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging.
Yang SR; Wright J; Bauter M; Seweryniak K; Kode A; Rahman I
Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L567-76. PubMed ID: 17041012
[TBL] [Abstract][Full Text] [Related]
13. Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model.
Jung-Hynes B; Schmit TL; Reagan-Shaw SR; Siddiqui IA; Mukhtar H; Ahmad N
J Pineal Res; 2011 Mar; 50(2):140-9. PubMed ID: 21062352
[TBL] [Abstract][Full Text] [Related]
14. High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells.
Kozako T; Aikawa A; Shoji T; Fujimoto T; Yoshimitsu M; Shirasawa S; Tanaka H; Honda S; Shimeno H; Arima N; Soeda S
Int J Cancer; 2012 Nov; 131(9):2044-55. PubMed ID: 22322739
[TBL] [Abstract][Full Text] [Related]
15. Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase.
Vergnes B; Vanhille L; Ouaissi A; Sereno D
Acta Trop; 2005 May; 94(2):107-15. PubMed ID: 15860278
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of SIRT1 deacetylase suppresses estrogen receptor signaling.
Yao Y; Li H; Gu Y; Davidson NE; Zhou Q
Carcinogenesis; 2010 Mar; 31(3):382-7. PubMed ID: 19995796
[TBL] [Abstract][Full Text] [Related]
17. The antiproliferative and apoptotic effects of sirtinol, a sirtuin inhibitor on human lung cancer cells by modulating Akt/β-catenin-Foxo3a axis.
Fong Y; Lin YC; Wu CY; Wang HM; Lin LL; Chou HL; Teng YN; Yuan SS; Chiu CC
ScientificWorldJournal; 2014; 2014():937051. PubMed ID: 25184156
[TBL] [Abstract][Full Text] [Related]
18. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
Alcendor RR; Kirshenbaum LA; Imai S; Vatner SF; Sadoshima J
Circ Res; 2004 Nov; 95(10):971-80. PubMed ID: 15486319
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.
Chen H; Tu SW; Hsieh JT
J Biol Chem; 2005 Jun; 280(23):22437-44. PubMed ID: 15817459
[TBL] [Abstract][Full Text] [Related]
20. SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis.
Nihal M; Ahmad N; Wood GS
Cell Cycle; 2014; 13(4):632-40. PubMed ID: 24343700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]